Yüksel Ürün/X
Feb 13, 2025, 07:41
Yüksel Ürün: SBRT, A powerful option for inoperable RCC
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Ludwige Abancourt, et al. on X:
“SBRT: A powerful option for inoperable RCC!
With 96% local control at 5 years, SBRT offers effective, non-invasive treatment while preserving renal function.”
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series.
Authors: Ludwige Abancourt, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 21:04
Apr 19, 2025, 20:48
Apr 19, 2025, 20:25
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17
Apr 19, 2025, 19:01
Apr 19, 2025, 18:42
Apr 19, 2025, 18:29